LivaNova (NASDAQ:LIVN) Receives Buy Rating from Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of LivaNova (NASDAQ:LIVN) in a research note released on Tuesday morning,Benzinga reports. They currently have a $75.00 price objective on the stock.

Other research analysts also recently issued research reports about the stock. Stifel Nicolaus increased their price objective on shares of LivaNova from $70.00 to $72.00 and gave the company a “buy” rating in a report on Thursday, July 25th. Robert W. Baird raised their price target on LivaNova from $66.00 to $72.00 and gave the company an “outperform” rating in a report on Thursday, October 31st. StockNews.com raised LivaNova from a “buy” rating to a “strong-buy” rating in a report on Friday, November 8th. The Goldman Sachs Group initiated coverage on shares of LivaNova in a research report on Friday, October 4th. They issued a “buy” rating and a $65.00 price target on the stock. Finally, Mizuho dropped their price objective on shares of LivaNova from $80.00 to $70.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $69.17.

LivaNova Stock Down 0.4 %

NASDAQ LIVN opened at $52.10 on Tuesday. The stock has a market cap of $2.83 billion, a PE ratio of 124.05 and a beta of 1.01. The company has a current ratio of 3.37, a quick ratio of 2.87 and a debt-to-equity ratio of 0.46. LivaNova has a 12 month low of $42.75 and a 12 month high of $64.47. The stock’s 50 day moving average is $51.77 and its 200 day moving average is $52.95.

Hedge Funds Weigh In On LivaNova

Hedge funds have recently added to or reduced their stakes in the company. Hexagon Capital Partners LLC lifted its stake in shares of LivaNova by 117.8% during the 2nd quarter. Hexagon Capital Partners LLC now owns 684 shares of the company’s stock worth $37,000 after acquiring an additional 370 shares during the last quarter. Fifth Third Bancorp grew its holdings in shares of LivaNova by 97.1% in the second quarter. Fifth Third Bancorp now owns 674 shares of the company’s stock worth $37,000 after purchasing an additional 332 shares during the last quarter. Lazard Asset Management LLC bought a new position in shares of LivaNova in the first quarter worth about $84,000. Canada Pension Plan Investment Board purchased a new position in LivaNova in the 2nd quarter worth about $88,000. Finally, Acadian Asset Management LLC bought a new stake in LivaNova during the 1st quarter valued at about $94,000. 97.64% of the stock is currently owned by institutional investors.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.